United States Dementia Cases Estimated to Double by 2060

- Anticipated Jump Especially Large for Women, Blacks, and Those Over Age 75

NEW YORK, Jan. 13, 2025 /PRNewswire/ -- A new study shows that the risk of developing dementia anytime after age 55 among Americans is 42%, more than double the risk reported by older studies.  

That dementia risk translates into an estimated half-million cases this year, rising to 1 million new cases a year by 2060, according to the new work. Dementia involves progressive declines in memory, concentration, and judgment. The increasing number of cases is directly tied to the aging of the U.S. population. Beyond aging, a high risk of dementia is linked to genetic factors, as well as high rates of hypertension and diabetes, obesity, unhealthy diets, lack of exercise, and poor mental health.

The study authors attribute the previous underestimates of dementia risk to unreliable documentation of the illness in health records and on death certificates, minimal surveillance of early-stage cases of dementia, and the underreporting of cases among racial minority groups, who are disproportionately vulnerable.

This large study is a collaboration funded by the National Institutes of Health to NYU Langone Health and includes authors from Johns Hopkins University and other U.S. institutions. The new study relies on information gathered from the ongoing Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS), which, since 1987, has closely tracked the vascular health and cognitive function of nearly 16,000 participants as they age. ARIC-NCS is also, the researchers say, the longest-followed cohort of African-Americans for cognition and heart health.

Publishing in the journal Nature Medicine online Jan. 13, the study concludes that from 1987 until 2020, there were 3,252 study participants who were documented as having developed dementia. This translates to an overall lifetime risk for dementia among middle-aged Americans of 42%, which is an average of the 35% risk in men and the 48% risk in women. The excess risk in women was largely due to their lower death rates.

The new results also showed a higher risk among Black adults and in those who carried a variant of the APOE4 gene (between 45% and 60%), which codes for a protein that carries cholesterol and other lipids in the bloodstream. Having a certain version of APOE4 is thought to be the single biggest genetic risk factor in developing late-onset Alzheimer's disease.

"Our study results forecast a dramatic rise in the burden from dementia in the United States over the coming decades, with one in two Americans expected to experience cognitive difficulties after age 55," said study senior investigator and epidemiologist Josef Coresh, MD, PhD, who serves as the founding director of the Optimal Aging Institute at NYU Langone.

Coresh, the Terry and Mel Karmazin Professor in the Department of Population Health and a professor in the Department of Medicine at NYU Grossman School of Medicine, says the expected rise in dementia cases is partly tied to the facts that a progressive decline in brain function is often observed starting in middle age, that women overall live longer on average than men, and that about 58 million Americans are now over age 65. Among the study's other key findings was that the lifetime risk of dementia increases to over 50% among those who reach age 75.

However, previous findings from this study and others indicate that policies designed to prevent heart disease, such as blood pressure control and diabetes prevention, should also slow cognitive decline and prevent dementia. 

"The pending population boom in dementia cases poses significant challenges for health policymakers, in particular, who must refocus their efforts on strategies to minimize the severity of dementia cases, as well as plans to provide more health care services for those with dementia," said Coresh.

Loss of hearing among older adults has also been tied to increased risk of dementia. However, only a third of Americans with hearing loss use hearing aids. To address this, Coresh recommends greater monitoring and testing, and possibly even government assistance programs to support healthy hearing among the elderly, including making hearing aids more widely available and affordable.

Coresh also argues that far more resources are needed to address racial inequities in health care, noting that while dementia numbers among White individuals are expected to double over the next four decades, rates among Black individuals are expected to triple. Health policies should heighten efforts in Black communities to improve childhood education and nutrition, which he says previous research has shown to be beneficial in staving off cognitive decline later in life.

For the latest analysis, researchers used data from the ARIC-NCS study and then modeled their projections of lifetime risk using information from the U.S. Census Bureau.

Funding support for the studies was provided by National Institutes of Health grants K24HL152440, K01DK138273, R01AG054787, 75N92022D00001, 75N92022D00002, 75N92022D00003, 75N92022D00004, 75N92022D00005, U01HL096812, U01HL096814, U01HL096899, U01HL096902, and U01Hl096917.

Besides Coresh, another NYU Langone researcher involved in this study is co-investigator Jordan Weiss, PhD.

Michael Fang, PhD, at Johns Hopkins University in Baltimore, Md., is the lead author of the study.

Other co-investigators and authors include Jiaqi Hu, MS; Marilyn Albert, PhD; A. Richey Sharrett, MD, DrPH; and Elizabeth Selvin, MPH, PhD, at Johns Hopkins; David Knopman, MD, at the Mayo Clinic in Rochester, Minn.; B. Gwen Windham, MHS, MD, and Thomas Mosley, PhD, at the University of Mississippi in Oxford; Keenan Walker, PhD, at the National Institute on Aging in Baltimore; Rebecca Gottesman, MD, PhD, at the National Institute of Neurological Disorders and Stroke in Bethesda, Md.; and Pamela Lutsey, PhD, MPH, at the University of Minnesota in Minneapolis.

About NYU Langone Health
NYU Langone Health is a fully integrated health system that consistently achieves the best patient outcomes through a rigorous focus on quality that has resulted in some of the lowest mortality rates in the nation. Vizient, Inc., has ranked NYU Langone the No. 1 comprehensive academic medical center in the country for three years in a row, and U.S. News & World Report recently placed nine of its clinical specialties among the top five in the nation. NYU Langone offers a comprehensive range of medical services with one high standard of care across six inpatient locations, its Perlmutter Cancer Center, and more than 300 outpatient locations in the New York area and Florida. With $14.2 billion in revenue this year, the system also includes two tuition-free medical schools, in Manhattan and on Long Island, and a vast research enterprise with over $1 billion in active awards from the National Institutes of Health.

Media Inquiries
David March
212-404-3528
[email protected]

SOURCE NYU Langone Health System